-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Cutera (NASDAQ:CUTR) Shares Up 6.4%
Cutera (NASDAQ:CUTR) Shares Up 6.4%
Cutera, Inc. (NASDAQ:CUTR – Get Rating) shot up 6.4% on Friday . The company traded as high as $46.35 and last traded at $46.12. 10,166 shares were traded during mid-day trading, a decline of 96% from the average session volume of 272,935 shares. The stock had previously closed at $43.34.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on CUTR. Piper Sandler lowered their price target on Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. TheStreet downgraded Cutera from a "c-" rating to a "d+" rating in a research note on Thursday, July 7th. StockNews.com upgraded Cutera to a "sell" rating in a research note on Friday, September 2nd. Finally, Maxim Group restated a "buy" rating and set a $80.00 price objective on shares of Cutera in a research note on Friday, August 5th.
Get Cutera alerts:Cutera Stock Performance
The stock has a market capitalization of $903.03 million, a P/E ratio of -12.38 and a beta of 1.84. The stock has a 50 day moving average of $47.51 and a 200 day moving average of $49.36. The company has a debt-to-equity ratio of 12.56, a quick ratio of 3.83 and a current ratio of 4.36.
Cutera (NASDAQ:CUTR – Get Rating) last announced its quarterly earnings results on Thursday, August 4th. The medical device company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.01). Cutera had a negative return on equity of 151.43% and a negative net margin of 27.62%. The business had revenue of $64.22 million for the quarter, compared to analyst estimates of $63.42 million. During the same quarter last year, the firm posted $0.39 EPS. The company's revenue was up 9.6% compared to the same quarter last year. Equities analysts predict that Cutera, Inc. will post -1.88 EPS for the current year.Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the business. Prelude Capital Management LLC boosted its position in Cutera by 19,653.8% during the 2nd quarter. Prelude Capital Management LLC now owns 908,475 shares of the medical device company's stock worth $1,173,000 after acquiring an additional 903,876 shares during the period. ExodusPoint Capital Management LP acquired a new stake in shares of Cutera in the second quarter valued at $883,000. Goldman Sachs Group Inc. lifted its holdings in shares of Cutera by 2.5% in the second quarter. Goldman Sachs Group Inc. now owns 32,473 shares of the medical device company's stock valued at $1,218,000 after buying an additional 778 shares during the period. Jane Street Group LLC lifted its holdings in shares of Cutera by 105.4% in the second quarter. Jane Street Group LLC now owns 30,124 shares of the medical device company's stock valued at $1,129,000 after buying an additional 15,457 shares during the period. Finally, Thrivent Financial for Lutherans lifted its holdings in shares of Cutera by 22.1% in the second quarter. Thrivent Financial for Lutherans now owns 16,238 shares of the medical device company's stock valued at $609,000 after buying an additional 2,935 shares during the period.
About Cutera
(Get Rating)
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
Featured Stories
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
Cutera, Inc. (NASDAQ:CUTR – Get Rating) shot up 6.4% on Friday . The company traded as high as $46.35 and last traded at $46.12. 10,166 shares were traded during mid-day trading, a decline of 96% from the average session volume of 272,935 shares. The stock had previously closed at $43.34.
卡特拉公司(納斯達克代碼:Cutr-Get Rating)週五暴漲6.4%。該公司股價一度高達46.35美元,最新報46.12美元。午盤成交量為10,166股,較272,935股的平均成交量下降96%。該股此前收盤價為43.34美元。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
A number of brokerages have recently weighed in on CUTR. Piper Sandler lowered their price target on Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. TheStreet downgraded Cutera from a "c-" rating to a "d+" rating in a research note on Thursday, July 7th. StockNews.com upgraded Cutera to a "sell" rating in a research note on Friday, September 2nd. Finally, Maxim Group restated a "buy" rating and set a $80.00 price objective on shares of Cutera in a research note on Friday, August 5th.
最近,許多券商都加入了Cutr的行列。派珀·桑德勒在8月5日週五的一份報告中將他們對Cutera的目標價從65.00美元下調至55.00美元,並對該公司設定了“增持”評級。華爾街在7月7日星期四的一份研究報告中將Cutera的評級從“c-”下調至“d+”。在9月2日星期五的一份研究報告中,StockNews.com將Cutera的評級上調至“賣出”。最後,Maxim Group在8月5日星期五的一份研究報告中重申了“買入”評級,併為Cutera的股票設定了80.00美元的目標價。
Cutera Stock Performance
Cutera股票表現
The stock has a market capitalization of $903.03 million, a P/E ratio of -12.38 and a beta of 1.84. The stock has a 50 day moving average of $47.51 and a 200 day moving average of $49.36. The company has a debt-to-equity ratio of 12.56, a quick ratio of 3.83 and a current ratio of 4.36.
該股市值為9.0303億美元,市盈率為-12.38,貝塔係數為1.84。該股的50日移動均線切入位為47.51美元,200日移動均線切入位為49.36美元。該公司的負債權益比率為12.56,速動比率為3.83,流動比率為4.36。
Institutional Inflows and Outflows
機構資金流入和流出
A number of institutional investors have recently added to or reduced their stakes in the business. Prelude Capital Management LLC boosted its position in Cutera by 19,653.8% during the 2nd quarter. Prelude Capital Management LLC now owns 908,475 shares of the medical device company's stock worth $1,173,000 after acquiring an additional 903,876 shares during the period. ExodusPoint Capital Management LP acquired a new stake in shares of Cutera in the second quarter valued at $883,000. Goldman Sachs Group Inc. lifted its holdings in shares of Cutera by 2.5% in the second quarter. Goldman Sachs Group Inc. now owns 32,473 shares of the medical device company's stock valued at $1,218,000 after buying an additional 778 shares during the period. Jane Street Group LLC lifted its holdings in shares of Cutera by 105.4% in the second quarter. Jane Street Group LLC now owns 30,124 shares of the medical device company's stock valued at $1,129,000 after buying an additional 15,457 shares during the period. Finally, Thrivent Financial for Lutherans lifted its holdings in shares of Cutera by 22.1% in the second quarter. Thrivent Financial for Lutherans now owns 16,238 shares of the medical device company's stock valued at $609,000 after buying an additional 2,935 shares during the period.
一些機構投資者最近增持或減持了該業務的股份。Prelude Capital Management LLC在第二季度將其在Cutera的頭寸增加了19,653.8%。Prelude Capital Management LLC在此期間額外收購了903,876股,現在擁有這家醫療器械公司908,475股股票,價值1,173,000美元。ExodusPoint Capital Management LP在第二季度收購了Cutera的新股份,價值883,000美元。高盛股份有限公司在第二季度增持了2.5%的Cutera股票。高盛股份有限公司目前持有這家醫療器械公司32,473股股票,價值1,218,000美元,在此期間又購買了778股。簡街集團在第二季度增持了105.4%的卡特拉股票。簡街集團現在擁有30,124股這家醫療設備公司的股票,價值1,129,000美元,在此期間又購買了15,457股。最後,Thrient Financial for Lutherans在第二季度增持了22.1%的Cutera股票。ThriventFinancial for Lutherans現在擁有這家醫療設備公司16,238股票,價值609,000美元,在此期間又購買了2,935股票。
About Cutera
關於Cutera
(Get Rating)
(獲取評級)
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
Cutera,Inc.是一家醫療器械公司,研究、開發、製造、營銷激光和基於能量的美學系統,併為全球從業者提供服務。該公司推出了Secret PRO,這是一種利用分數二氧化碳進行皮膚表面重塑和射頻微針進行深層真皮重塑的設備;truSculpt flex,一種生物電肌肉刺激設備,可以治療各種健康水平的患者;EXCEL V+,一種血管和良性色素病變治療平臺;truSculpt ID,用於非手術身體造型市場;Secret RF,一種用於組織凝固和止血的分數射頻微針系統。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
- 免費獲取StockNews.com關於Cutera的研究報告(Cutr)
- 這是買入美光科技的難忘時刻
- 雷神工業走出谷底
- Keurig Dr Pepper與規模更大的競爭對手可口可樂(Coke&Pepsi)相比如何?
- 讓Paychex股票為您努力工作
- 利潤下降對CarMax價值主張的挑戰
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Cutera Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cutera和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧